Koers Bristol-Myers Squibb Company Wiener Boerse
Aandelen
BMYS
US1101221083
Farmaceutische producten
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
39,21 EUR | +1,10% | +2,04% | -16,32% |
Omzet 2024 * | 46,09 mld. 42,98 mld. | Omzet 2025 * | 46,06 mld. 42,95 mld. | Marktkapitalisatie | 86,29 mld. 80,48 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -5,41 mld. -5,05 mld. | Nettowinst (verlies) 2025 * | 10,22 mld. 9,53 mld. | EV/omzet 2024 * | 2,72 x |
Nettoschuld 2024 * | 39,03 mld. 36,4 mld. | Nettoschuld 2025 * | 31,68 mld. 29,54 mld. | EV/omzet 2025 * | 2,56 x |
K/w-verhouding 2024 * |
-16,2
x | K/w-verhouding 2025 * |
8,05
x | Werknemers | 34.100 |
Dividendrendement 2024 * |
5,65% | Dividendrendement 2025 * |
5,93% | Vrij verhandelbaar | 69,27% |
Recentste transcriptie over Bristol-Myers Squibb Company
1 dag | +1,10% | ||
1 week | +2,04% | ||
Lopende maand | +3,04% | ||
1 maand | -6,49% | ||
3 maanden | -21,25% | ||
6 maanden | -16,86% | ||
Lopend jaar | -16,32% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 53 | 01-02-15 | |
David Elkins
DFI | Director of Finance/CFO | 55 | 20-11-19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 20-11-19 |
Peter Arduini
BRD | Director/Board Member | 59 | 01-04-16 |
Derica Rice
BRD | Director/Board Member | 59 | 01-09-20 |
Datum | Koers | Variatie |
---|---|---|
10-06-24 | 38,78 | +1,07% |
07-06-24 | 38,38 | +1,62% |
06-06-24 | 37,76 | -0,45% |
05-06-24 | 37,94 | -1,08% |
04-06-24 | 38,35 | +0,89% |
slotkoers Wiener Boerse, 10 juni 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+46,87% | 779 mld. | |
+40,65% | 631 mld. | |
-7,12% | 354 mld. | |
+19,77% | 333 mld. | |
+9,63% | 301 mld. | |
+16,85% | 249 mld. | |
-1,96% | 216 mld. | |
+10,66% | 214 mld. | |
+4,25% | 163 mld. |